Alyeska Investment Group Portfolio holdings
AUM
$28.2B
This Quarter Return
-3.02%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$8.53B
AUM Growth
+$8.53B
(-2.3%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
693
New
132
Increased
102
Reduced
118
Closed
319
Top Buys
| 1 |
Adobe
ADBE
|
$136M |
| 2 |
SAP
SAP
|
$124M |
| 3 |
Ciena
CIEN
|
$121M |
| 4 |
Illumina
ILMN
|
$103M |
| 5 |
Veeva Systems
VEEV
|
$98.4M |
Top Sells
| 1 |
Atlassian
TEAM
|
$151M |
| 2 |
Paycom
PAYC
|
$108M |
| 3 |
Workday
WDAY
|
$106M |
| 4 |
Elastic
ESTC
|
$78.9M |
| 5 |
CDW
CDW
|
$77M |
Sector Composition
| 1 | Technology | 27.21% |
| 2 | Healthcare | 17.05% |
| 3 | Industrials | 14.44% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Energy | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Procter & Gamble
PG
$368B
| – | – | -244,564 | Closed | -$35.2M |
|
677
Pagaya Technologies
PGY
$2.83B
| – | – | -141,614 | Closed | -$592K |
|
678
PNC Financial Services
PNC
$81.7B
| – | – | -44,000 | Closed | -$6.94M |
|
679
PROS Holdings
PRO
$746M
| – | – | -731,585 | Closed | -$19.2M |
|
680
ProKidney
PROK
$319M
| – | – | -420,837 | Closed | -$4.19M |
|
681
Pure Storage
PSTG
$25.4B
| – | – | -60,085 | Closed | -$1.55M |
|
682
Peloton Interactive
PTON
$3.1B
| – | – | -236,922 | Closed | -$2.18M |
|
683
Rapid7
RPD
$1.34B
| – | – | -444,163 | Closed | -$29.7M |
|
684
Royalty Pharma
RPRX
$15.6B
| – | – | -354,729 | Closed | -$14.9M |
|
685
Range Resources
RRC
$8.16B
| – | – | -458,794 | Closed | -$11.4M |
|
686
Sunrun
RUN
$3.68B
| – | – | -277,500 | Closed | -$6.48M |
|
687
Rezolute
RZLT
$619M
| – | – | -50,000 | Closed | -$162K |
|
688
Saia
SAIA
$7.9B
| – | – | -30,968 | Closed | -$5.82M |
|
689
Satellogic
SATL
$394M
| – | – | -33,058 | Closed | -$135K |
|
690
Starbucks
SBUX
$100B
| – | – | -7,906 | Closed | -$604K |
|
691
Charles Schwab
SCHW
$174B
| – | – | -400,237 | Closed | -$25.3M |
|
692
SCYNEXIS
SCYX
$34.9M
| – | – | -150,000 | Closed | -$279K |
|
693
SELLAS Life Sciences
SLS
$202M
| – | – | -254,018 | Closed | -$566K |
|